{"log_id": 8683596130871518392, "direction": 0, "words_result_num": 32, "words_result": [{"probability": {"variance": 0.000776, "average": 0.99337, "min": 0.821411}, "location": {"width": 774, "top": 191, "height": 33, "left": 172}, "words": "【药理毒理】本品为半合成的麦角碱衍生物。有α受体阻滞作用和血管扩张作用。可加强脑"}, {"probability": {"variance": 0.00595, "average": 0.98534, "min": 0.505095}, "location": {"width": 781, "top": 233, "height": 32, "left": 164}, "words": "细胞能量的新陈代谢,增加氧和葡萄糖的利用。可促进神经递质多巴胺的转换而增加神经作"}, {"probability": {"variance": 4e-06, "average": 0.998872, "min": 0.993034}, "location": {"width": 383, "top": 276, "height": 27, "left": 165}, "words": "导,加强脑部蛋白质生物合成,改善脑功能"}, {"probability": {"variance": 6e-06, "average": 0.999004, "min": 0.984137}, "location": {"width": 751, "top": 319, "height": 28, "left": 202}, "words": "毒理研究表明,尼麦角林口服有很大的安全范围。在大鼠和狗的长期给药试验中,在临"}, {"probability": {"variance": 2e-06, "average": 0.999132, "min": 0.993282}, "location": {"width": 768, "top": 361, "height": 27, "left": 162}, "words": "床给药剂量的五倍时,出现不良反应,超过临床规定剂量的十倍以上时出现毒性反应。行"}, {"probability": {"variance": 2.3e-05, "average": 0.997732, "min": 0.972722}, "location": {"width": 789, "top": 402, "height": 29, "left": 163}, "words": "为、试验室检查和病理组织学方面的毒性评估为阴性,尼麦角林对生育力、妊娠、分娩、哺"}, {"probability": {"variance": 2e-06, "average": 0.998984, "min": 0.992935}, "location": {"width": 540, "top": 443, "height": 27, "left": 158}, "words": "乳期和后代的正常发育无影响。尼麦角林无致突变和致癌作用"}, {"probability": {"variance": 2.8e-05, "average": 0.997619, "min": 0.968278}, "location": {"width": 759, "top": 525, "height": 30, "left": 166}, "words": "【药代动力学】尼麦角林在口服给药后迅速并且几乎完全吸收。绝对生物利用度小于5%"}, {"probability": {"variance": 0.009371, "average": 0.963745, "min": 0.580099}, "location": {"width": 799, "top": 567, "height": 27, "left": 159}, "words": "尼麦角林的主要代谢产物为MMDL(1,6-二甲基-8β一羟甲基一10α-甲氧基一尼麦角林)和"}, {"probability": {"variance": 0.025162, "average": 0.938164, "min": 0.430915}, "location": {"width": 790, "top": 605, "height": 33, "left": 161}, "words": "ML(6-二甲基-8β一羟甲基10-甲氧基一尼麦角林)。尼麦角林大部分(>90%)与血"}, {"probability": {"variance": 0.001166, "average": 0.987787, "min": 0.844041}, "location": {"width": 779, "top": 645, "height": 33, "left": 157}, "words": "浆蛋白结合,对血α一酸糖蛋白的亲和力高于血清蛋白。在大鼠中,给[标记的尼麦角林"}, {"probability": {"variance": 2.7e-05, "average": 0.998053, "min": 0.970096}, "location": {"width": 752, "top": 689, "height": 27, "left": 196}, "words": "g/kg),肝脏的放射活性最高。其次为肾脏、肺、胰腺、唾液、淋巴、脾、肾上腺和心"}, {"probability": {"variance": 0.00896, "average": 0.969748, "min": 0.49477}, "location": {"width": 787, "top": 727, "height": 30, "left": 156}, "words": "肌。脑中的放射活性低于血中。给[防]和[C]标记的尼麦角林后,肾排泄是放射活性的"}, {"probability": {"variance": 0.005604, "average": 0.983674, "min": 0.511102}, "location": {"width": 780, "top": 767, "height": 32, "left": 157}, "words": "主要衰减途径(约占总量的80%)。粪便中的放射活性只占总量的10-20%。在四组年轻"}, {"probability": {"variance": 0.001989, "average": 0.985562, "min": 0.74216}, "location": {"width": 781, "top": 808, "height": 31, "left": 164}, "words": "(平均24-32岁)和老年人(平均69-70岁)的志愿者中进行研究,对得到的药代动力学"}, {"probability": {"variance": 8e-06, "average": 0.99866, "min": 0.984342}, "location": {"width": 769, "top": 849, "height": 30, "left": 156}, "words": "参数分别比较,结果显示尼麦角林的药代动力学不受年龄影响。有严重肾功能不全的患者"}, {"probability": {"variance": 0.000114, "average": 0.995592, "min": 0.93646}, "location": {"width": 788, "top": 890, "height": 27, "left": 156}, "words": "尿中的MDL和MDL的排泄显著减少。在单剂量口服给30mg尼麦角林后,轻度、中度或严重"}, {"probability": {"variance": 0.000121, "average": 0.995943, "min": 0.931468}, "location": {"width": 781, "top": 930, "height": 27, "left": 153}, "words": "的肾功能不全的患者,与肾功能正常的相比,MDL尿中的排泄量分别平均减少32、32和59"}, {"probability": {"variance": 0, "average": 1, "min": 1}, "location": {"width": 23, "top": 970, "height": 23, "left": 154}, "words": "%"}, {"probability": {"variance": 0.000167, "average": 0.995666, "min": 0.920988}, "location": {"width": 728, "top": 1010, "height": 30, "left": 205}, "words": "在国内进行了生物利用度试验,12名健康受试者口服60mg国产的尼麦角林薄膜衣片"}, {"probability": {"variance": 9.8e-05, "average": 0.994379, "min": 0.956149}, "location": {"width": 755, "top": 1049, "height": 29, "left": 154}, "words": "10mg/片,6片)后,估算的MDL的消除半衰期为8.1±1.6小时,峰时间和峰浓度分别为"}, {"probability": {"variance": 0.001856, "average": 0.98432, "min": 0.70376}, "location": {"width": 759, "top": 1091, "height": 28, "left": 150}, "words": "2.7±1.2小时和1018±23.0ng/ml。12名健康受试者口服60mg国产的尼麦角林薄膜衣片"}, {"probability": {"variance": 0.006343, "average": 0.977153, "min": 0.521897}, "location": {"width": 733, "top": 1129, "height": 28, "left": 156}, "words": "30mg/片,2片)店,估算的MDL的消除半衰期为8.5±2小时,峰时间和峰浓度分别为"}, {"probability": {"variance": 0.019791, "average": 0.949142, "min": 0.430413}, "location": {"width": 255, "top": 1167, "height": 26, "left": 149}, "words": "2.6±1.1小时和102.8±30.5"}, {"probability": {"variance": 0, "average": 0.96223, "min": 0.96223}, "location": {"width": 29, "top": 1157, "height": 27, "left": 483}, "words": "2"}, {"probability": {"variance": 0.054949, "average": 0.737042, "min": 0.408801}, "location": {"width": 104, "top": 1190, "height": 45, "left": 366}, "words": "√国"}, {"probability": {"variance": 3e-06, "average": 0.998138, "min": 0.994502}, "location": {"width": 217, "top": 1248, "height": 26, "left": 158}, "words": "【贮藏】遮光、密封保存"}, {"probability": {"variance": 5.2e-05, "average": 0.997608, "min": 0.971665}, "location": {"width": 243, "top": 1327, "height": 27, "left": 154}, "words": "【包装】铝塑包装,30片/盒"}, {"probability": {"variance": 3e-06, "average": 0.998663, "min": 0.99477}, "location": {"width": 160, "top": 1409, "height": 25, "left": 155}, "words": "【有效期】36个月"}, {"probability": {"variance": 0.002152, "average": 0.974964, "min": 0.821471}, "location": {"width": 285, "top": 1487, "height": 24, "left": 153}, "words": "【执行标准】WS1-(X-256)-2004Z"}, {"probability": {"variance": 3.9e-05, "average": 0.995349, "min": 0.982131}, "location": {"width": 99, "top": 1530, "height": 24, "left": 504}, "words": "第3页共4页"}, {"probability": {"variance": 1.4e-05, "average": 0.99289, "min": 0.986413}, "location": {"width": 70, "top": 1552, "height": 18, "left": 232}, "words": "20081202"}], "language": 3}